Psychedelics have taken the world by storm with research focused on treating neuropsychiatric disorders like depression and anxiety. While it is understood that psychedelics cause hallucinations and changes in perception through activation in the serotonin 2A receptor (5-HT2AR) in humans and rodents,1,2 the mechanisms behind their potential therapeutic effects still remain a mystery.


Previous articlePsychedelic Bulletin: Proliferation of Psilocybin-Related Drug Development; Biden-Harris Administration Aims to Reduce Barriers to Schedule I Research
Next articleNeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets